ASCO 2016 Update: Immunotherapy and Melanoma

Harold Burstein, Elizabeth Buchbinder

Harold J. Burstein, MD, PhD (right), discusses the latest immunotherapy research with Elizabeth Buchbinder, MD (left).

As one of the hottest topics in cancer research today, immunotherapy took center stage at the 2016 American Society of Clinical Oncology meeting in Chicago. Harold J. Burstein, MD, PhD, a breast oncologist in the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute, recently sat down with other oncologists to break down some of the meeting’s more important findings.

Below, he talks with Elizabeth I. Buchbinder, MD, a melanoma specialist, about some of the research related to pembrolizumab (Keytruda), which was used to treat former President Jimmy Carter, and other immunotherapy news.

Watch additional ASCO video updates and learn about other important research presentations.

Comments Sort By Newest

One thought on “ASCO 2016 Update: Immunotherapy and Melanoma

Comments are closed.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
As recently as up to 10 years ago, #ovariancancer patients had fewer options for treatment. Targeted therapies have… https://t.co/tPLFcyIwpN
Dana-Farber @danafarber
When bone marrow can no longer keep up with the body's needs for new blood cells, it can lead to serious consequenc… https://t.co/gMhLId8U0y
Dana-Farber @danafarber
Itchy skin has many causes, including dryness & allergies, but only rarely does it signal that a person has cancer:… https://t.co/jZfr7PbBfq

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.